Patent intelligence · US
US 10368569
Natural sweetener
Natural sweetener
Patent details — US 10368569
- Jurisdiction
- US
- Status
- granted
- Grant date
- Aug 6, 2019
- Expiration
- Aug 1, 2039
- Applicant
- MONTERO GIDA SANAYI VE TICARET A.S.
- Claims
- 26
- CPC classes
- A61K, A61K47/12, A61K47/14, A61K47/183
Quick answer
US 10368569 (Natural sweetener) is held by MONTERO GIDA SANAYI VE TICARET A.S.. Status: granted. Granted Aug 6, 2019. Expires Aug 1, 2039 (13 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- MONTERO GIDA SANAYI VE TICARET A.S.
- Grant date
- Expiration
- Claims
- 26
- CPC classes
- A61K, A61K47/12, A61K47/14, A61K47/183, A61K47/46, A61K9/0053
More from MONTERO GIDA SANAYI VE TICARET A.S.
Related pharmaceutical patents in our USPTO index.
-
US 12391663
Isoindolinone compounds
granted -
US 12378199
Rigidified pentadentate chelating agents useful for the [Al18F]2+ labelling of biomolecules
granted -
US 12280029
Methods of treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic modulators
granted -
US 12263143
Ionic channel modulation as a method for treating tumors through inflammasome activation
granted -
US 12257247
Targeted degradation of VAV1
granted -
US 12214218
Perfusion modulated tumor dose sculpting with single dose radiotherapy
granted -
US 12070628
Low energy immune priming for treating cancer and metastasis
granted -
US 12011619
Low intensity focused ultrasound for treating cancer and metastasis
granted
Frequently asked questions
What is US patent 10368569?
US 10368569 (Natural sweetener) is held by MONTERO GIDA SANAYI VE TICARET A.S.. Status: granted. Granted Aug 6, 2019. Expires Aug 1, 2039 (13 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10368569?
MONTERO GIDA SANAYI VE TICARET A.S. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 72 pharmaceutical patents for this assignee.
When does US 10368569 expire?
Our index shows an expiration date of Aug 1, 2039 (13 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.